Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1623 1693
This examiner grants 52% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18539559 | OIL-RESISTANT AGENT | Final Rejection | DAIKIN INDUSTRIES, LTD. |
| 18365835 | METHODS FOR THE TREATMENT OF FAMILIAL HETEROZYGOUS AND HOMOZYGOUS HYPERCHOLESTEROLEMIA WITH CYCLODEXTRINS | Non-Final OA | Beren Therapeutics P.B.C. |
| 18627239 | DOSING REGIMENS FOR USE IN PREVENTING RELAPSE OF ACUTE MYELOID LEUKEMIA FOLLOWING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION WITH VENETOCLAX IN COMBINATION WITH AZACITIDINE | Non-Final OA | ABBVIE INC. |
| 19380466 | 4'-HALOGEN CONTAINING NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO | Final Rejection | EMORY UNIVERSITY |
| 18031832 | CRYSTALLINE POLYMORPHIC FORMS OF STING AGONISTS ASSOCIATED WITH METAL IONS CAPABLE OF MODULATING AN IMMUNE RESPONSE | Non-Final OA | The Regents of the University of Michigan |
| 17616966 | METHODS OF REJUVENATING AGED TISSUE BY INHIBITING 15-HYDROXYPROSTAGLANDIN DEHYDROGENASE (15-PGDH) | Final Rejection | The Board of Trustees of the Leland Stanford Junior University |
| 18543979 | DISULFIDE CONTAINING THERAPEUTICS | Non-Final OA | Singular Genomics Systems, Inc. |
| 18255757 | STABLE AQUEOUS COMPOSITION FOR PRETERM TO PROMOTE EARLY POSTNAL GROWTH | Non-Final OA | SOCIETE DES PRODUITS NESTLE S.A. |
| 17265387 | METHODS FOR REDUCING ABNORMAL SCAR FORMATION | Non-Final OA | CORNELL UNIVERSITY |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy